Skip to main content
Egyptian Liver Journal

Table 3 Comparison between groups I and II according to HCC recurrence

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

 

Group I (n = 50), no. (%)

Group II (n = 50), no. (%)

χ2

p

HCC recurrence

19 (38%)

31 (62%)

5.760*

0.016*

  1. *Statistically significant at p ≤ 0.05
Back to article page